305 related articles for article (PubMed ID: 11437650)
1. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.
He Q; Riley RT; Sharma RP
Toxicol Appl Pharmacol; 2001 Jul; 174(1):69-77. PubMed ID: 11437650
[TBL] [Abstract][Full Text] [Related]
2. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase.
Enongene EN; Sharma RP; Bhandari N; Miller JD; Meredith FI; Voss KA; Riley RT
Toxicol Sci; 2002 Jun; 67(2):173-81. PubMed ID: 12011476
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological antagonism of fumonisin B1 cytotoxicity in porcine renal epithelial cells (LLC-PK1): a model for reducing fumonisin-induced nephrotoxicity in vivo.
He Q; Riley RT; Sharma RP
Pharmacol Toxicol; 2002 May; 90(5):268-77. PubMed ID: 12076308
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of sphingolipid biosynthesis decreases phosphorylated ERK2 in LLC-PK1 cells.
Rentz SS; Showker JL; Meredith FI; Riley RT
Food Chem Toxicol; 2005 Jan; 43(1):123-31. PubMed ID: 15582204
[TBL] [Abstract][Full Text] [Related]
5. Fumonisin B1 consumption by rats causes reversible, dose-dependent increases in urinary sphinganine and sphingosine.
Wang E; Riley RT; Meredith FI; Merrill AH
J Nutr; 1999 Jan; 129(1):214-20. PubMed ID: 9915902
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor necrosis factor alpha signaling by anti-tumor necrosis factor alpha antibodies and pentoxifylline is unable to prevent fumonisin hepatotoxicity in mice.
He Q; Sharma RP
Toxicon; 2005 Sep; 46(4):404-13. PubMed ID: 16054185
[TBL] [Abstract][Full Text] [Related]
7. Tolerance to fumonisin toxicity in a mouse strain lacking the P75 tumor necrosis factor receptor.
Sharma RP; Bhandari N; Riley RT; Voss KA; Meredith FI
Toxicology; 2000 Feb; 143(2):183-94. PubMed ID: 10755704
[TBL] [Abstract][Full Text] [Related]
8. Fumonisin B(1) induces apoptosis in LLC-PK(1) renal epithelial cells via a sphinganine- and calmodulin-dependent pathway.
Kim MS; Lee DY; Wang T; Schroeder JJ
Toxicol Appl Pharmacol; 2001 Oct; 176(2):118-26. PubMed ID: 11601888
[TBL] [Abstract][Full Text] [Related]
9. The mycotoxin fumonisin B1 transiently activates nuclear factor-kappaB, tumor necrosis factor alpha and caspase 3 via protein kinase Calpha-dependent pathway in porcine renal epithelial cells.
Gopee NV; Sharma RP
Cell Biol Toxicol; 2004 Jul; 20(4):197-212. PubMed ID: 15499968
[TBL] [Abstract][Full Text] [Related]
10. Sphingoid bases and their phosphates: transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity.
Gopee NV; Sharma RP
Toxicology; 2003 May; 187(2-3):239-50. PubMed ID: 12699912
[TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide has protective effect on fumonisin B1 hepatotoxicity in mice via modulation of sphingosine kinase.
Suzuki H; Riley RT; Sharma RP
Toxicology; 2007 Jan; 229(1-2):42-53. PubMed ID: 17095132
[TBL] [Abstract][Full Text] [Related]
12. Fumonisin B1-induced apoptosis is associated with delayed inhibition of protein kinase C, nuclear factor-kappaB and tumor necrosis factor alpha in LLC-PK1 cells.
Gopee NV; He Q; Sharma RP
Chem Biol Interact; 2003 Oct; 146(2):131-45. PubMed ID: 14597127
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases.
Schmelz EM; Dombrink-Kurtzman MA; Roberts PC; Kozutsumi Y; Kawasaki T; Merrill AH
Toxicol Appl Pharmacol; 1998 Feb; 148(2):252-60. PubMed ID: 9473533
[TBL] [Abstract][Full Text] [Related]
15. Elevation of sphinganine 1-phosphate as a predictive biomarker for fumonisin exposure and toxicity in mice.
Kim DH; Yoo HS; Lee YM; Kie JH; Jang S; Oh S
J Toxicol Environ Health A; 2006 Dec; 69(23):2071-82. PubMed ID: 17060094
[TBL] [Abstract][Full Text] [Related]
16. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity.
He Q; Riley RT; Sharma RP
Food Chem Toxicol; 2005 Jun; 43(6):969-79. PubMed ID: 15811577
[TBL] [Abstract][Full Text] [Related]
17. Elevation of sphingoid base 1-phosphate as a potential contributor to hepatotoxicity in fumonisin B1-exposed mice.
Kim DH; Lee YS; Lee YM; Oh S; Yun YP; Yoo HS
Arch Pharm Res; 2007 Aug; 30(8):962-9. PubMed ID: 17879749
[TBL] [Abstract][Full Text] [Related]
18. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.
Yoo HS; Norred WP; Showker J; Riley RT
Toxicol Appl Pharmacol; 1996 Jun; 138(2):211-8. PubMed ID: 8658522
[TBL] [Abstract][Full Text] [Related]
19. Gender-related differences in subacute fumonisin B1 hepatotoxicity in BALB/c mice.
Bhandari N; He Q; Sharma RP
Toxicology; 2001 Aug; 165(2-3):195-204. PubMed ID: 11522378
[TBL] [Abstract][Full Text] [Related]
20. Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of N-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitor.
Humpf HU; Schmelz EM; Meredith FI; Vesper H; Vales TR; Wang E; Menaldino DS; Liotta DC; Merrill AH
J Biol Chem; 1998 Jul; 273(30):19060-4. PubMed ID: 9668088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
